Adverum Biotechnologies (ADVM) Earnings Date, Estimates & Call Transcripts $2.46 -0.13 (-5.02%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$2.54 +0.08 (+3.21%) As of 06/13/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Adverum Biotechnologies Earnings Summary Adverum Biotechnologies posted Q4 2024 earnings on April 15, 2025, reporting an EPS of -$1.96, which missed analysts' consensus estimates of -$1.34 by $0.62. With a trailing EPS of -$6.40, Adverum Biotechnologies' earnings are expected to decrease next year, from ($4.92) to ($5.20) per share. Upcoming Earnings DateAug. 11Before Market OpensEstimatedConsensus EPS (Apr. 15) -$1.34 Actual EPS (Apr. 15) -$1.96 Missed By -$0.62 Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)ADVM Upcoming EarningsAdverum Biotechnologies' next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules. Powered by Get Adverum Biotechnologies Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Adverum Biotechnologies and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataADVM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ADVM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Adverum Biotechnologies Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$2.25-$2.25-$2.25Q3 20251-$1.19-$1.19-$1.19Q4 20251-$1.17-$1.17-$1.17 Adverum Biotechnologies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/11/2025(Estimated)--------4/15/2025Q4 2024-$1.34-$1.96 -$0.62-$1.96--11/4/2024--$1.20-$1.30 -$0.10-$1.30$0.50M$1.00M8/12/2024Q2 2024-$1.47-$0.89+$0.58-$0.89$0.53M-5/9/2024Q1 2024-$1.28-$1.50 -$0.22-$1.50--3/18/2024Q4 2023-$2.80-$2.30+$0.50-$2.30--11/9/2023Q3 2023-$3.00-$3.30 -$0.30-$0.33--8/10/2023Q2 2023-$3.20-$3.10+$0.10-$0.31-- Adverum Biotechnologies Earnings - Frequently Asked Questions When is Adverum Biotechnologies' earnings date? Adverum Biotechnologies has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on ADVM's earnings history. Did Adverum Biotechnologies beat their earnings estimates last quarter? In the previous quarter, Adverum Biotechnologies (NASDAQ:ADVM) missed the analysts' consensus estimate of ($1.34) by $0.62 with a reported earnings per share (EPS) of ($1.96). Learn more on analysts' earnings estimate vs. ADVM's actual earnings. How much revenue does Adverum Biotechnologies generate each year? Adverum Biotechnologies (NASDAQ:ADVM) has a recorded annual revenue of $1 million. How much profit does Adverum Biotechnologies generate each year? Adverum Biotechnologies (NASDAQ:ADVM) has a recorded net income of -$117.17 million. ADVM has generated -$6.40 earnings per share over the last four quarters. What is Adverum Biotechnologies' EPS forecast for next year? Adverum Biotechnologies' earnings are expected to decrease from ($4.92) per share to ($5.20) per share in the next year. More Earnings Resources from MarketBeat Related Companies Esperion Therapeutics Earnings Date DBV Technologies Earnings Date MediWound Earnings Date Y-mAbs Therapeutics Earnings Date Instil Bio Earnings Date Acelyrin Earnings Date I-Mab Earnings Date Design Therapeutics Earnings Date scPharmaceuticals Earnings Date 4D Molecular Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:ADVM) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adverum Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adverum Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADVM Stock Free ADVM Stock Alerts